Azerbaijan vs Colombia: Cause of death, by non-communicable diseases, male
Azerbaijan
51.0%
in 2021
Colombia
50.7%
in 2021
Azerbaijan rank
113th
Colombia rank
114th
Cause of death, by non-communicable diseases, male over time
- Azerbaijan
- Colombia
How they compare
Azerbaijan currently reports 51.0% against 50.7% in Colombia, a difference of 0.3%.
Across all 6 years both countries report, Azerbaijan has been ahead every year.
Azerbaijan ranks 113th and Colombia ranks 114th of 185 countries.
Azerbaijan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.7% | 47.5% | 23.2% | Azerbaijan |
| 2010s | 80.9% | 63.9% | 17.0% | Azerbaijan |
| 2020s | 57.5% | 53.6% | 3.9% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Azerbaijan or Colombia?
- Azerbaijan, at 51.0% against 50.7% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Azerbaijan and Colombia?
- 0.3%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Colombia?
- 6 years are reported by both, from 2000 to 2021.
- How do Azerbaijan and Colombia rank globally for cause of death, by non-communicable diseases, male?
- Azerbaijan ranks 113th and Colombia ranks 114th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.